State Administration of Ukraine on Medicinal Products permitted Farmak JSC to resume manufacturing of the medicinal products

State Administration of Ukraine on Medicinal Products (SAUMP) permitted Farmak JSC to resume manufacturing of the medicinal products, based on the Order No 1810 dated 30 December 2013.

According to the Order issued by SAUMP, it is permitted to resume manufacturing of the following medicinal products:

• PINOSOL®, nasal spray, solution 10 mL per vial № 1 in set with a pump dispenser with nasal spray (Registration Certificate No UA/6606/01/01);
• URONEPHRON®, gel, 100 g per package in tubes (Registration Certificate No UA/11226/01/01);
• CORVALOL®, oral drops, 25 ml, 50 ml per vial № 1 (Registration Certificate No UA/2554/01/01);
• CORVALOL® N, oral drops, 25 ml per vial, № 1 in package (Registration Certificate No UA/3684/01/01);
• CORVALDIN®, oral drops, 25 ml or 50 ml per vial (Registration Certificate No UA/2553/01/01);
• CORVALOL®, tablets № 10×1, № 10×3, № 10×5 packed in blisters (Registration Certificate No UA/2554/02/01);
• FLENOX®, solution for injections, 10000 anti-Ха IU 0,2ml (2000 anti-Ха IU) or 0,4 ml (4000 anti-Ха IU) or 0,6 ml (6000 anti-Ха IU) in syringe; 1 syringe per blister; 1, 2 or 10 blisters per cardboard package; 0,2 ml (2000 anti-Ха IU) or 0,4 ml (4000 anti-Ха IU) or 0,6 ml (6000 anti-Ха IU) in syringe; 2 syringes per blister; 1 or 5 blisters per cardboard package; 0,8 ml (8000 anti-Ха IU) in syringe; 1 syringe per blister; 1 or 2 blisters per cardboard package; 0,8 ml (8000 anti-Ха IU) in syringe; 2 syringes per blister; 1 blister per cardboard package (Registration Certificate No UA/13119/01/01);
• FLENOX®, solution for injections, 10000 anti-Ха IU 0,2ml (2000 anti-Ха IU) or 0,4 ml (4000 anti-Ха IU) or 0,6 ml (6000 anti-Ха IU) in syringe; 1 syringe per blister; 1, 2 or 10 blisters per cardboard package; 0,2 ml (2000 anti-Ха IU) or 0,4 ml (4000 anti-Ха IU) or 0,6 ml (6000 anti-Ха IU) in syringe; 2 syringes per blister; 1 or 5 blisters per cardboard package; 0,8 ml (8000 anti-Ха IU) in syringe; 1 syringe per blister; 1 or 2 blisters per cardboard package; 0,8 ml (8000 anti-Ха IU) in syringe; 2 syringes per blister; 1 blister per cardboard package (packed in-bulk of the production company Hangzhou Jiuyuan Gene Engineering Co., Ltd., China) (Registration Certificate No UA/9353/01/01);
• NAZOFERON®, nasal drops 100 000 MO/ml, 5 ml per glass vial № 1 (Registration Certificate No 657/11-300200000);
• NAZOFERON®, nasal spray 100 000 MO/ml, 5 ml per glass vial № 1 (Registration Certificate No 862/11-300200000).

More news

Farmak participated in the first Voluntary National Rev...

On July 15, 2020 the first Voluntary National Review of progress towards the Sustainable Development Goals was presented by Ukraine to the world community.  The UN Global Compact Network Ukraine prepared the Review of Business Progress in Ukraine towards the Sustainable Development Goals which included Farmak, the only company representing the Ukrainian phar...

Jul 15, 2020

Farmak increased manufacturing capacity by 35% and redu...

Farmak increased manufacturing capacity by 35% and reduced gas and electricity consumption by 76% and 64% respectively for 5 years, emission release is annually reduced by an average of 12-20% over this period This is stated in Farmak’s non-financial report on corporate social responsibility which the Company has prepared in accordance with the commitments t...

Jul 15, 2020

The biography book about Filya Zhebrovska was published

The book Visionary (in Ukrainian: Vizioner («Візіонер»)) about Filya Zhebrovska, the owner of the largest Ukrainian pharmaceutical company Farmak, was published in April by Burda Publishing House. The biography tells about the life of a person who managed to steer the Soviet enterprise out of the crisis and transform it into a modern European manufacturing [...

Jun 22, 2020